Research priorities to address polypharmacy in older adults with cancer

Prithviraj, 2012, Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer, J Geriatr Oncol, 3, 228, 10.1016/j.jgo.2012.02.005 Nightingale, 2015, Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer, J Clin Oncol, 33, 1453, 10.1200/JCO.2014.58.7550 Sharma, 2016, Polypharmacy and potentially inappropriate medication use in geriatric oncology, J Geriatr Oncol, 7, 346, 10.1016/j.jgo.2016.07.010 Mohamed, 2020, Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: a systematic review and meta-analysis, Oncologist, 25, 10.1634/theoncologist.2019-0406 Nightingale, 2017, The impact of polypharmacy on patient outcomes in older adults with cancer, Cancer J, 23, 211 Goh, 2018, Prevalence and risk of polypharmacy among elderly cancer patients receiving chemotherapy in ambulatory oncology setting, Curr Oncol Rep, 20, 38, 10.1007/s11912-018-0686-x Leger, 2018, Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: observational single-center study of 122 patients, J Geriatr Oncol, 9, 60, 10.1016/j.jgo.2017.07.015 Lund, 2018, Potential medication-related problems in older breast, colon, and lung cancer patients in the United States, Cancer Epidemiol Prevent Biomark, 27, 41, 10.1158/1055-9965.EPI-17-0523 Jørgensen, 2020, The influence of polypharmacy, potentially inappropriate medications, and drug interactions on treatment completion and prognosis in older patients with ovarian cancer, J Geriatr Oncol, 11, 593, 10.1016/j.jgo.2019.12.005 van Loveren, 2020, Prevalence and follow-up of potentially inappropriate medication and potentially omitted medication in older patients with cancer–The PIM POM study, J Geriatr Oncol Sweiss, 2020, Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician–pharmacist clinic, J Oncol Pharm Pract, 26, 536, 10.1177/1078155219851550 Dhakal, 2020, Prevalence and effects of polypharmacy on overall survival in acute myeloid leukemia, Leuk Lymphoma, 10, 1 Choukroun, 2020, Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer, J Geriatr Oncol Turner, 2016, Polypharmacy cut-points in older people with cancer: how many medications are too many?, Support Care Cancer, 24, 1831, 10.1007/s00520-015-2970-8 Mohamed MR, Ramsdale E, Loh KP, Xu H, Patil A, Gilmore N, Wells M, Nightingale G, Juba KM, Faller B, Onitilio A, Bradley T, Culakova E, Holmes HM, Mohile SG. Association of polypharmacy and potentially inappropriate medications with physical functional impairments in older adults with cancer. J Natl Compr Canc Netw [In press]. Cadogan, 2016, Appropriate polypharmacy and medicine safety: when many is not too many, Drug Saf, 39, 109, 10.1007/s40264-015-0378-5 2019 American Geriatrics Society Beers Criteria® Update Expert Panel, 2019, Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults, J Am Geriatr Soc O’Mahony, 2010, STOPP & START criteria: a new approach to detecting potentially inappropriate prescribing in old age, Eur Geriatr Med, 1, 45, 10.1016/j.eurger.2010.01.007 Samsa, 1994, A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity, J Clin Epidemiol, 47, 891, 10.1016/0895-4356(94)90192-9 Whitman, 2016, A comprehensive look at polypharmacy and medication screening tools for the older cancer patient, Oncologist, 21, 723, 10.1634/theoncologist.2015-0492 Lindsay, 2015, The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’, Support Care Cancer, 23, 71, 10.1007/s00520-014-2322-0 Garfinkel, 2010, Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy, Arch Intern Med, 170, 1648, 10.1001/archinternmed.2010.355 American Society of Hospital Pharmacist, 1993, ASHP statement on pharmaceutical care, Am J Hosp Pharm, 50, 1720 Nightingale, 2018, The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software, J Geriatr Oncol, 9, 526, 10.1016/j.jgo.2018.02.001 Popa, 2014, Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy, J Geriatr Oncol, 5, 307, 10.1016/j.jgo.2014.04.002 Beinse, 2020, Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: a survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort, J Geriatr Oncol, 11, 586, 10.1016/j.jgo.2019.07.023 Sharma, 2019, The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer, Cancer., 125, 1155, 10.1002/cncr.31917 Scott, 2015, Reducing inappropriate polypharmacy: the process of deprescribing, JAMA Intern Med, 175, 827, 10.1001/jamainternmed.2015.0324 Bain, 2008, Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process, J Am Geriatr Soc, 56, 1946, 10.1111/j.1532-5415.2008.01916.x Van der Linden, 2019, Medication review in older adults: importance of time to benefit, Am J Health Syst Pharm, 15 George, 2004, Development and validation of the medication regimen complexity index, Ann Pharmacother, 38, 1369, 10.1345/aph.1D479 Libby, 2013, Patient-level medication regimen complexity across populations with chronic disease, Clin Ther, 35, 385, 10.1016/j.clinthera.2013.02.019 Pantuzza, 2017, Association between medication regimen complexity and pharmacotherapy adherence: a systematic review, Eur J Clin Pharmacol, 73, 1475, 10.1007/s00228-017-2315-2 Lund, 2020, Changes in chronic medication adherence in older adults with cancer versus matched cancer-free cohorts, J Geriatr Oncol Mislang, 2017, Adherence to oral cancer therapy in older adults: the International Society of Geriatric Oncology (SIOG) taskforce recommendations, Cancer Treat Rev, 57, 58, 10.1016/j.ctrv.2017.05.002 Williams, 2016, Comorbidity in older adults with cancer, J Geriatr Oncol, 7, 249, 10.1016/j.jgo.2015.12.002 Turner, 2020, Optimising medications for patients with cancer and multimorbidity: the case for deprescribing, Clin Oncol, 17 Nightingale, 2019, Clinical pharmacology of oncology agents in older adults: a comprehensive review of how chronologic and functional age can influence treatment-related effects, J Geriatr Oncol, 10, 4, 10.1016/j.jgo.2018.06.008 Hurria, 2008, Clinical pharmacology of cancer therapies in older adults, Br J Cancer, 98, 517, 10.1038/sj.bjc.6604201 Kenis, 2017, Functional decline in older patients with cancer receiving chemotherapy: a multicenter prospective study, J Geriatr Oncol, 8, 196, 10.1016/j.jgo.2017.02.010 van Abbema, 2017, Functional status decline in older patients with breast and colorectal cancer after cancer treatment: a prospective cohort study, J Geriatr Oncol, 8, 176, 10.1016/j.jgo.2017.01.003 Magnuson, 2019, A practical guide to geriatric syndromes in older adults with cancer: a focus on falls, cognition, polypharmacy, and depression, Am Soc Clin Oncol Educ Book, 39, e96, 10.1200/EDBK_237641 Hanlon, 2017, Study. Potential drug–drug and drug–disease interactions in well-functioning community-dwelling older adults, J Clin Pharm Ther, 42, 228, 10.1111/jcpt.12502 Lindblad, 2006, Clinically important drug-disease interactions and their prevalence in older adults, Clin Ther, 28, 1133, 10.1016/j.clinthera.2006.08.006 Goldberg, 1996, Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population, Am J Emerg Med, 14, 447, 10.1016/S0735-6757(96)90147-3 Peron, 2011, Medication use and functional status decline in older adults: a narrative review, Am J Geriatr Pharmacother, 9, 378, 10.1016/j.amjopharm.2011.10.002 Gutiérrez-Valencia, 2018, The relationship between frailty and polypharmacy in older people: a systematic review, Br J Clin Pharmacol, 84, 1432, 10.1111/bcp.13590 Sattar, 2020, Falls in older patients with cancer: Nursing and Allied Health Group of International Society of Geriatric Oncology review paper, J Geriatr Oncol, 11, 1, 10.1016/j.jgo.2019.03.020 Sattar, 2016, Falls in older adults with cancer: a systematic review of prevalence, injurious falls, and impact on cancer treatment, Support Care Cancer, 24, 4459, 10.1007/s00520-016-3342-8 Wildes, 2015, Systematic review of falls in older adults with cancer, J Geriatr Oncol, 6, 70, 10.1016/j.jgo.2014.10.003 Korc-Grodzicki, 2015, Prevention of post-operative delirium in older patients with cancer undergoing surgery, J Geriatr Oncol, 6, 60, 10.1016/j.jgo.2014.10.002 Weinrich, 1994, Delirium in the older person with cancer, Cancer., 74, 2079, 10.1002/1097-0142(19941001)74:7+<2079::AID-CNCR2820741716>3.0.CO;2-0 Magnuson, 2016, Cognition and cognitive impairment in older adults with cancer, Curr Geriatr Rep, 5, 213, 10.1007/s13670-016-0182-9 Boyle, 2008, Cognitive impairment in older adults with cancer, J Natl Cancer Inst, 100, 630 Loh, 2016, Chemotherapy-related cognitive impairment in older patients with cancer, J Geriatr Oncol, 7, 270, 10.1016/j.jgo.2016.04.008 2018 Moore, 1999, Drug-induced cognitive impairment in the elderly, Drugs Aging, 15, 15, 10.2165/00002512-199915010-00002 Campbell, 2009, The cognitive impact of anticholinergics: a clinical review, Clin Interv Aging, 4, 225 Fox, 2011, Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study, J Am Geriatr Soc, 59, 1477, 10.1111/j.1532-5415.2011.03491.x Nightingale, 2019, Potentially inappropriate medication use and cognition in older women with breast cancer: a prospective pilot study, J Geriatr Oncol, 10, S71, 10.1016/S1879-4068(19)31237-8 Galvin, 2018, Sociodemographic, socioeconomic, and clinical determinants of survival in patients with cancer: a systematic review of the literature focused on the elderly, J Geriatr Oncol, 9, 6, 10.1016/j.jgo.2017.07.007 Du, 2007, Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer, Cancer: Interdisc Int J Am Cancer Soc, 110, 660, 10.1002/cncr.22826 Assari, 2019, Race/ethnicity, socioeconomic status, and polypharmacy among older Americans, Pharmacy., 7, 41, 10.3390/pharmacy7020041 Assari, 2019, Polypharmacy in African American adults: a national epidemiological study, Pharmacy., 7, 33, 10.3390/pharmacy7020033 Spees, 2020, Changes in chronic medication adherence, costs, and health care use after a cancer diagnosis among low-income patients and the role of patient-centered medical homes, Cancer., 126, 4770, 10.1002/cncr.33147 Whitman, 2018, Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study, Support Care Cancer, 26, 4105, 10.1007/s00520-018-4281-3 Nightingale, 2017, Implementing a pharmacist-led, individualized medication assessment and planning (iMAP) intervention to reduce medication related problems among older adults with cancer, J Geriatr Oncol, 8, 296, 10.1016/j.jgo.2017.04.005 Deliens, 2016, Drugs prescribed for patients hospitalized in a geriatric oncology unit: potentially inappropriate medications and impact of a clinical pharmacist, J Geriatr Oncol, 7, 463, 10.1016/j.jgo.2016.05.001 Yeoh, 2015, Drug-related problems in elderly patients with cancer receiving outpatient chemotherapy, J Geriatr Oncol, 6, 280, 10.1016/j.jgo.2015.05.001 Ramsdale, 2018, Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers, J Geriatr Oncol, 9, 534, 10.1016/j.jgo.2018.02.007 Caillet, 2011, Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study, J Clin Oncol, 29, 3636, 10.1200/JCO.2010.31.0664 Kalsi, 2015, The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people, Br J Cancer, 112, 1435, 10.1038/bjc.2015.120 Aparicio, 2011, A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study, Crit Rev Oncol Hematol, 77, 63, 10.1016/j.critrevonc.2010.01.003 Curran, 2012, Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact, Med Care, 50, 217, 10.1097/MLR.0b013e3182408812 Landes, 2020, Reprint of: an introduction to effectiveness-implementation hybrid designs, Psychiatry Res, 283, 112630, 10.1016/j.psychres.2019.112630 Conklin, 2019, Implementing deprescribing guidelines into frontline practice: barriers and facilitators, Res Social Adm Pharm, 15, 796, 10.1016/j.sapharm.2018.08.012 Farrell, 2019, Deprescribing guidelines: an international symposium on development, implementation, research and health professional education, Res Social Adm Pharm, 15, 780, 10.1016/j.sapharm.2018.08.010 Mecca, 2019, Assessing an interprofessional polypharmacy and deprescribing educational intervention for primary care post-graduate trainees: a quantitative and qualitative evaluation, J Gen Intern Med, 34, 1220, 10.1007/s11606-019-04932-9